Lifeline Biotechnologies Stock Price Patterns
| LLBO Stock | USD 0.0005 0.0001 16.67% |
Momentum 49
Impartial
Oversold | Overbought |
Using Lifeline Biotechnologies hype-based prediction, you can estimate the value of Lifeline Biotechnologies from the perspective of Lifeline Biotechnologies response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Lifeline Biotechnologies to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Lifeline because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Lifeline Biotechnologies after-hype prediction price | USD 5.99E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Lifeline |
Lifeline Biotechnologies After-Hype Price Density Analysis
As far as predicting the price of Lifeline Biotechnologies at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Lifeline Biotechnologies or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Lifeline Biotechnologies, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Lifeline Biotechnologies Estimiated After-Hype Price Volatility
In the context of predicting Lifeline Biotechnologies' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Lifeline Biotechnologies' historical news coverage. Lifeline Biotechnologies' after-hype downside and upside margins for the prediction period are 0.00 and 15.14, respectively. We have considered Lifeline Biotechnologies' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Lifeline Biotechnologies is out of control at this time. Analysis and calculation of next after-hype price of Lifeline Biotechnologies is based on 3 months time horizon.
Lifeline Biotechnologies Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Lifeline Biotechnologies is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Lifeline Biotechnologies backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Lifeline Biotechnologies, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.16 | 15.27 | 0.18 | 0.03 | 8 Events / Month | 2 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.0005 | 0.0006 | 19.83 |
|
Lifeline Biotechnologies Hype Timeline
Lifeline Biotechnologies is now traded for 0.0005. The entity has historical hype elasticity of -0.18, and average elasticity to hype of competition of -0.03. Lifeline is forecasted to increase in value after the next headline, with the price projected to jump to 5.99E-4 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is estimated to be 19.83%, whereas the daily expected return is now at 0.16%. The volatility of related hype on Lifeline Biotechnologies is about 7673.37%, with the expected price after the next announcement by competition of -0.03. Lifeline Biotechnologies currently holds 448.07 K in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. Lifeline Biotechnologies has a current ratio of 8.25, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Lifeline Biotechnologies until it has trouble settling it off, either with new capital or with free cash flow. So, Lifeline Biotechnologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Lifeline Biotechnologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Lifeline to invest in growth at high rates of return. When we think about Lifeline Biotechnologies' use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out Lifeline Biotechnologies Basic Forecasting Models to cross-verify your projections.Lifeline Biotechnologies Related Hype Analysis
Having access to credible news sources related to Lifeline Biotechnologies' direct competition is more important than ever and may enhance your ability to predict Lifeline Biotechnologies' future price movements. Getting to know how Lifeline Biotechnologies' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Lifeline Biotechnologies may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| NUMD | Nu Med Plus | 0.00 | 0 per month | 0.00 | (0.10) | 0.00 | (13.33) | 55.96 | |
| PLLWF | Polarean Imaging plc | 0.00 | 0 per month | 0.00 | 0.14 | 0.00 | (23.33) | 644.63 | |
| IRME | International Display Advertising | (1.15) | 4 per month | 18.23 | 0.05 | 25.07 | (28.33) | 210.00 | |
| TLIS | Talis Biomedical Corp | (0.84) | 17 per month | 0.00 | 0.12 | 0.00 | 0.00 | 77.50 | |
| RHEP | Regional Health Properties | 0.00 | 0 per month | 4.02 | 0.01 | 9.49 | (8.76) | 30.85 | |
| RQHTF | Reliq Health Technologies | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| USAQ | USA Equities Corp | 0.00 | 0 per month | 7.30 | 0.18 | 34.38 | (14.71) | 79.51 | |
| BNVIF | Binovi Technologies Corp | 0.00 | 0 per month | 0.00 | 0.12 | 0.00 | 0.00 | 844.44 | |
| AXIM | Axim Biotechnologies | 0.00 | 0 per month | 8.97 | 0.13 | 21.43 | (15.79) | 76.67 | |
| BIOE | Bio Essence | 0.00 | 0 per month | 0.00 | (0.08) | 2.90 | (9.84) | 37.85 |
Lifeline Biotechnologies Additional Predictive Modules
Most predictive techniques to examine Lifeline price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Lifeline using various technical indicators. When you analyze Lifeline charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Lifeline Biotechnologies Predictive Indicators
The successful prediction of Lifeline Biotechnologies stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Lifeline Biotechnologies, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Lifeline Biotechnologies based on analysis of Lifeline Biotechnologies hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Lifeline Biotechnologies's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Lifeline Biotechnologies's related companies.
Pair Trading with Lifeline Biotechnologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lifeline Biotechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lifeline Biotechnologies will appreciate offsetting losses from the drop in the long position's value.Moving against Lifeline Pink Sheet
| 0.53 | DXCM | DexCom Inc Earnings Call This Week | PairCorr |
| 0.51 | EC | Ecopetrol SA ADR | PairCorr |
| 0.5 | MDT | Medtronic PLC | PairCorr |
| 0.5 | CDLR | Cadeler AS | PairCorr |
| 0.44 | PHJMF | PT Hanjaya Mandala | PairCorr |
| 0.44 | ECO | Okeanis Eco Tankers | PairCorr |
The ability to find closely correlated positions to Lifeline Biotechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lifeline Biotechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lifeline Biotechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lifeline Biotechnologies to buy it.
The correlation of Lifeline Biotechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lifeline Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lifeline Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lifeline Biotechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Lifeline Pink Sheet
Lifeline Biotechnologies financial ratios help investors to determine whether Lifeline Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lifeline with respect to the benefits of owning Lifeline Biotechnologies security.